Product Code: ETC6176855 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Central Nervous System (CNS) Stimulants Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Central Nervous System (CNS) Stimulants Market - Industry Life Cycle |
3.4 Australia Central Nervous System (CNS) Stimulants Market - Porter's Five Forces |
3.5 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Central Nervous System (CNS) Stimulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Australia |
4.2.2 Growing awareness about mental health and related treatments |
4.2.3 Technological advancements leading to the development of innovative CNS stimulants |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for CNS stimulants |
4.3.2 High costs associated with CNS stimulant medications |
4.3.3 Potential side effects and risks associated with CNS stimulants |
5 Australia Central Nervous System (CNS) Stimulants Market Trends |
6 Australia Central Nervous System (CNS) Stimulants Market, By Types |
6.1 Australia Central Nervous System (CNS) Stimulants Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Phendimetrazine, 2021- 2031F |
6.1.4 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Phentermine, 2021- 2031F |
6.1.5 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Methamphetamine, 2021- 2031F |
6.1.6 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Dextroamphetamine, 2021- 2031F |
6.1.7 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Central Nervous System (CNS) Stimulants Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Major Depressive Disorder, 2021- 2031F |
6.2.3 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Anxiety Disorders, 2021- 2031F |
6.2.4 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Attention Deficit Hyperactivity Disorder, 2021- 2031F |
6.2.5 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Central Nervous System (CNS) Stimulants Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Central Nervous System (CNS) Stimulants Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Central Nervous System (CNS) Stimulants Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Australia Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia Central Nervous System (CNS) Stimulants Market Import-Export Trade Statistics |
7.1 Australia Central Nervous System (CNS) Stimulants Market Export to Major Countries |
7.2 Australia Central Nervous System (CNS) Stimulants Market Imports from Major Countries |
8 Australia Central Nervous System (CNS) Stimulants Market Key Performance Indicators |
8.1 Number of clinical trials for new CNS stimulant drugs |
8.2 Adoption rate of non-pharmacological interventions for CNS disorders |
8.3 Rate of prescriptions for CNS stimulants vs. alternative treatments |
9 Australia Central Nervous System (CNS) Stimulants Market - Opportunity Assessment |
9.1 Australia Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Australia Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Australia Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Australia Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Central Nervous System (CNS) Stimulants Market - Competitive Landscape |
10.1 Australia Central Nervous System (CNS) Stimulants Market Revenue Share, By Companies, 2024 |
10.2 Australia Central Nervous System (CNS) Stimulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |